Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377018084> ?p ?o ?g. }
- W4377018084 endingPage "114894" @default.
- W4377018084 startingPage "114894" @default.
- W4377018084 abstract "Postmenopausal osteoporosis is the most common type of osteoporosis. Chondroitin sulfate (CS) has been successfully employed as food supplement against osteoarthritis, while the therapeutic potential on postmenopausal osteoporosis is little explored. In this study, CS oligosaccharides (CSOs) were enzymatically prepared through the lysis of CS by a chondroitinase from Microbacterium sp. Strain. The alleviating effects of CS, CSOs and Caltrate D (a clinically used supplement) on ovariectomy (OVX) - induced rat's osteoporosis were comparatively investigated. Our data showed that the prepared CSOs was basically unsaturated CS disaccharide mixture of ∆Di4S (53.1%), ∆Di6S (27.7%) and ∆Di0S (17.7%). 12 weeks' intragastric administration of Caltrate D (250 mg/kg/d), CS or CSOs (500 mg/kg/d, 250 mg/kg/d, 125 mg/kg/d) could obviously regulate the disorder of serum indices, recover the mechanical strength and mineral content of bone, improve the cortical bones' density and the number and length of trabecular bones in OVX rats. Both CS and CSOs in 500 mg/kg/d and 250 mg/kg/d could restore more efficiently the serum indices, bone fracture deflection and femur Ca than Caltrate D. As compared with CS at the same dosage, CSOs exhibited a more significant alleviating effect. These findings suggested that there was great potential of CSOs as daily interventions for delaying the progression of postmenopausal osteoporosis." @default.
- W4377018084 created "2023-05-19" @default.
- W4377018084 creator A5005620931 @default.
- W4377018084 creator A5067450737 @default.
- W4377018084 creator A5077626458 @default.
- W4377018084 creator A5084265319 @default.
- W4377018084 creator A5089053508 @default.
- W4377018084 creator A5089660433 @default.
- W4377018084 date "2023-08-01" @default.
- W4377018084 modified "2023-09-25" @default.
- W4377018084 title "Enzymatic preparation of chondroitin sulfate oligosaccharides and its alleviating effect on ovariectomy-induced osteoporosis in rats" @default.
- W4377018084 cites W1178570896 @default.
- W4377018084 cites W134050142 @default.
- W4377018084 cites W1497104265 @default.
- W4377018084 cites W1715492734 @default.
- W4377018084 cites W175660244 @default.
- W4377018084 cites W1966209629 @default.
- W4377018084 cites W1970160112 @default.
- W4377018084 cites W1971253488 @default.
- W4377018084 cites W1985061586 @default.
- W4377018084 cites W1987354408 @default.
- W4377018084 cites W1999122081 @default.
- W4377018084 cites W2000895478 @default.
- W4377018084 cites W2031050297 @default.
- W4377018084 cites W2041845245 @default.
- W4377018084 cites W2042919418 @default.
- W4377018084 cites W2045308024 @default.
- W4377018084 cites W2047495398 @default.
- W4377018084 cites W2049493406 @default.
- W4377018084 cites W2056742992 @default.
- W4377018084 cites W2058568261 @default.
- W4377018084 cites W2061310823 @default.
- W4377018084 cites W2064747498 @default.
- W4377018084 cites W2071425043 @default.
- W4377018084 cites W2075702924 @default.
- W4377018084 cites W2080080639 @default.
- W4377018084 cites W2086387656 @default.
- W4377018084 cites W2086596628 @default.
- W4377018084 cites W2108552642 @default.
- W4377018084 cites W2113576333 @default.
- W4377018084 cites W2119221073 @default.
- W4377018084 cites W2123346255 @default.
- W4377018084 cites W2131049610 @default.
- W4377018084 cites W2169791814 @default.
- W4377018084 cites W2171709369 @default.
- W4377018084 cites W2254543389 @default.
- W4377018084 cites W2292935897 @default.
- W4377018084 cites W2400667250 @default.
- W4377018084 cites W2464200499 @default.
- W4377018084 cites W2525769047 @default.
- W4377018084 cites W2531407875 @default.
- W4377018084 cites W2563966187 @default.
- W4377018084 cites W2609659251 @default.
- W4377018084 cites W2793246436 @default.
- W4377018084 cites W2802915131 @default.
- W4377018084 cites W2810929841 @default.
- W4377018084 cites W2905620157 @default.
- W4377018084 cites W2924809202 @default.
- W4377018084 cites W2971472479 @default.
- W4377018084 cites W2980064329 @default.
- W4377018084 cites W3000290005 @default.
- W4377018084 cites W3005535394 @default.
- W4377018084 cites W3044271894 @default.
- W4377018084 cites W3092349104 @default.
- W4377018084 cites W3093960267 @default.
- W4377018084 cites W3103322877 @default.
- W4377018084 cites W3128080313 @default.
- W4377018084 cites W3151206677 @default.
- W4377018084 cites W3158422152 @default.
- W4377018084 cites W3158620643 @default.
- W4377018084 cites W3159572077 @default.
- W4377018084 cites W3210734198 @default.
- W4377018084 cites W4210248478 @default.
- W4377018084 cites W4211221406 @default.
- W4377018084 cites W4220992533 @default.
- W4377018084 cites W4225134105 @default.
- W4377018084 cites W4235019470 @default.
- W4377018084 cites W4280627784 @default.
- W4377018084 cites W4309486135 @default.
- W4377018084 cites W4313379713 @default.
- W4377018084 cites W4319316589 @default.
- W4377018084 doi "https://doi.org/10.1016/j.biopha.2023.114894" @default.
- W4377018084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37209629" @default.
- W4377018084 hasPublicationYear "2023" @default.
- W4377018084 type Work @default.
- W4377018084 citedByCount "0" @default.
- W4377018084 crossrefType "journal-article" @default.
- W4377018084 hasAuthorship W4377018084A5005620931 @default.
- W4377018084 hasAuthorship W4377018084A5067450737 @default.
- W4377018084 hasAuthorship W4377018084A5077626458 @default.
- W4377018084 hasAuthorship W4377018084A5084265319 @default.
- W4377018084 hasAuthorship W4377018084A5089053508 @default.
- W4377018084 hasAuthorship W4377018084A5089660433 @default.
- W4377018084 hasBestOaLocation W43770180841 @default.
- W4377018084 hasConcept C126322002 @default.
- W4377018084 hasConcept C134018914 @default.
- W4377018084 hasConcept C141071460 @default.
- W4377018084 hasConcept C153074725 @default.